Meijides C. SARS-CoV 2 desde el sistema nervioso central. Revista Cubana de Investigaciones Biomédicas. 2020;39(4):e1115. [Consultado 16 Nov 2020]. Disponible en: http://www.revibiomedica.sld.cu/index.php/ibi/article/view/1115

Padrón-González AA, Dorta-Contreras AJ. Patogenia de las manifestaciones neurológicas asociadas al SARS-CoV-2. Revista Cubana de Investigaciones Biomédicas. 2020;39(3):e868. [Consultado 16 Nov 2020]. Disponible en: http://www.revibiomedica.sld.cu/index.php/ibi/article/view/868

Romero A, Ramos E, López-Muñoz F, Gil-Martín E, Escames G, Reiter RJ. Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin? Cell Mol Neurobiol. 2020:1-12.

Xu Y, Baylink DJ, Chen CS, Reeves ME, Xiao J, Lacy C, et al. The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19. J Transl Med. 2020;18(1):322.

Kempuraj D, Thangavel R, Kempuraj D, Ejaz M, Selvakumar G, Raikwar S. Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma. BioFactors. 2020;1-8.